Table 1.
SALIVA | BLOOD | |||||||||||
No. patients | No. samples | Median Age | Sex | No. patients | No. samples | Median Age | Sex | |||||
No. M | No. F |
No. M | No. F | |||||||||
All samples | 247 | 263 | - | 141 | 106 | All samples | 739 | 796 | - | 379 | 360 | |
Patients with COVID-19 | Cohort 1 | 47 | 54 | 61 | 28 | 19 | Patients with COVID-19 | 439 | 496 | 58 | 229 | 210 |
Cohort 2 | 81 | 90 | 58 | 48 | 33 | |||||||
Pre-COVID Negative Controls | Cohort 1 | 0 | 0 | 0 | 0 | 0 | Pre-COVID Negative Controls | 300 | 300 | 54.5 | 150 | 150 |
Cohort 2 | 27 | 27 | 43 | 12 | 15 | |||||||
Unexposed Negative Controls Collected in 2020 | Cohort 1 | 42 | 42 | 60 | 24 | 18 | ||||||
Cohort 2 | 50 | 50 | 58 | 29 | 21 | |||||||
Matched saliva-serum samples | 71 | 71 | 58 | 33 | 38 |